drugset
drugset / Trial / NCT02141412

Intravenous Dexmedetomidine For The Quaity Of Emergence From General Anesthesia

NCT02141412 ↗

Phase 4 Completed 216 enrolled American University of Beirut Medical Center
RandomizedParallel-groupDouble-blindPrevention

Summary

In a prospective randomized clinical trial involving adult patients undergoing elective surgery under general anesthesia, the investigators will enroll 216 patients, and evaluate 3 doses of prophylactic dexmedetomidine as a means to reduce postoperative shivering and quality of emergence from anesthesia versus placebo.

Timeline

Start
2009-09
Primary completion
2015-09
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.25 ug/kg Intravenous
Comparator Dexmedetomidine Other / unclassified 0.5 ug/kg Intravenous
Comparator Dexmedetomidine Other / unclassified 1 ug/kg Intravenous

Indications

benign shuddering attacks